Lafrence Andrew D.c. - Net Worth and Insider Trading

Lafrence Andrew D.c. Net Worth

The estimated net worth of Lafrence Andrew D.c. is at least $12,455 dollars as of 2024-05-11. Lafrence Andrew D.c. is the CFO of Vyant Bio Inc and owns about 64,202 shares of Vyant Bio Inc (VYNT) stock worth over $12,455. Details can be seen in Lafrence Andrew D.c.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lafrence Andrew D.c. has not made any transactions after 2021-11-23 and currently still holds the listed stock(s).

Transaction Summary of Lafrence Andrew D.c.

To

Lafrence Andrew D.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lafrence Andrew D.c. owns 2 companies in total, including Vyant Bio Inc (VYNT) , and KORU Medical Systems Inc (KRMD) .

Click here to see the complete history of Lafrence Andrew D.c.’s form 4 insider trades.

Insider Ownership Summary of Lafrence Andrew D.c.

Ticker Comapny Transaction Date Type of Owner
VYNT Vyant Bio Inc 2021-11-23 Chief Financial Officer
KRMD KORU Medical Systems Inc 2023-07-10 Chief Financial Officer

Lafrence Andrew D.c. Latest Holdings Summary

Lafrence Andrew D.c. currently owns a total of 1 stock. Lafrence Andrew D.c. owns 64,202 shares of Vyant Bio Inc (VYNT) as of November 23, 2021, with a value of $12,455.

Latest Holdings of Lafrence Andrew D.c.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VYNT Vyant Bio Inc 2021-11-23 64,202 0.19 12,455

Holding Weightings of Lafrence Andrew D.c.


Lafrence Andrew D.c. Form 4 Trading Tracker

According to the SEC Form 4 filings, Lafrence Andrew D.c. has made a total of 3 transactions in Vyant Bio Inc (VYNT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Vyant Bio Inc is the acquisition of 5,000 shares on November 23, 2021, which cost Lafrence Andrew D.c. around $10,000.

Insider Trading History of Lafrence Andrew D.c.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lafrence Andrew D.c. Trading Performance

GuruFocus tracks the stock performance after each of Lafrence Andrew D.c.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lafrence Andrew D.c. is -41.27%. GuruFocus also compares Lafrence Andrew D.c.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Lafrence Andrew D.c. within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lafrence Andrew D.c.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lafrence Andrew D.c.

Average Return

Average return per transaction

Outperforming Transactions

0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.65
Relative Return to S&P 500(%) -12.21

Lafrence Andrew D.c. Ownership Network

Ownership Network List of Lafrence Andrew D.c.

No Data

Ownership Network Relation of Lafrence Andrew D.c.


Lafrence Andrew D.c. Owned Company Details

What does Vyant Bio Inc do?

Who are the key executives at Vyant Bio Inc?

Lafrence Andrew D.c. is the Chief Financial Officer of Vyant Bio Inc. Other key executives at Vyant Bio Inc include Chief Executive Officer John A Roberts , director & Chief Innovation Officer Yung-ping Yeh , and Chief Scientific Officer Fremeau Robert Thomas Jr. .

Vyant Bio Inc (VYNT) Insider Trades Summary

Over the past 18 months, Lafrence Andrew D.c. made no insider transaction in Vyant Bio Inc (VYNT). Other recent insider transactions involving Vyant Bio Inc (VYNT) include a net sale of 765 shares made by Geoffrey E. Harris ,

In summary, during the past 3 months, insiders sold 0 shares of Vyant Bio Inc (VYNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 765 shares of Vyant Bio Inc (VYNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 765 shares.

Vyant Bio Inc (VYNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vyant Bio Inc Insider Transactions

No Available Data

Lafrence Andrew D.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Lafrence Andrew D.c.. You might contact Lafrence Andrew D.c. via mailing address: C/o Vyant Bio, Inc., 201 Route 17 North, 2nd Floor, Rutherford Nj 07070.

Discussions on Lafrence Andrew D.c.

No discussions yet.